# New York Blood Center Enterprises – FDA Inspection, Nov 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/c5d0fa69-163e-462a-83c2-e34a55cd287b
Source feed: FDA_Inspections

> FDA inspection 1036848 of New York Blood Center Enterprises, November 22, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036848
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2017-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1311062 - 2026-04-03](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/044a9fd6-4493-4d21-a1cf-9c768fb3add1)
- [FDA Inspection 1283668 - 2025-09-24](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/91ecba89-ae8a-4854-a2eb-f3ceac565d66)
- FDA Inspection 1217513 - 2023-09-07
- [FDA Inspection 1118178 - 2020-02-11](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/d7c05152-a755-44b7-acb6-8b9840cbb679)
- FDA Inspection 1064704 - 2018-08-07

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)
- [Company Rep](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Issuing Officer](https://www.keypedia.com/people/mercy-o-quagraine/c199b205-0142-43a0-ac9e-965aabf42265)

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
